Mithradote Bio
Latest round
- Seed
Last raised
- Oct 2024
Total raised
- $1M
Investors
- 2
About Mithradote Bio
Founded in 2023 and based in California, US, Mithradote Bio, Inc. develops M-101, a sublingual pan-antidote aimed at counteracting the effects of drug-facilitated sexual assault. The company was founded by its CEO, Sophia Lee. In October 2024, Mithradote Bio, Inc. and Vickers Venture Partners. Mithradote Bio engages in developing M-101, a novel sublingual pan-antidote that targets benzodiazepines, Z drugs, and other GABA agonists to counteract drug-facilitated sexual assault. M-101 is designed for rapid absorption and is intended for personal use, allowing individuals at risk to carry it discreetly. The primary users are individuals in social settings who may be vulnerable to such assaults. The company aims to expand its market reach in urban areas with higher incidences of these crimes, focusing on major cities in North America and Europe. Mithradote Bio utilizes a direct-to-consumer sales model for its flagship product, M-101, allowing consumers to purchase the antidote directly from the company. The firm is exploring potential partnerships with healthcare providers to increase its distribution footprint, which could include bulk purchase options or subscription models.
Who invested in Mithradote Bio
2 investors across 1 round
See all investors in Mithradote Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 2, 2024
Amount
$1M
Investors
Questions about Mithradote Bio
Who invested in Mithradote Bio?
Mithradote Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mithradote Bio raised?
Mithradote Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mithradote Bio last raise money?
Mithradote Bio's most recent round on record is a Seed, in Oct 2024.
What does Mithradote Bio do?
Founded in 2023 and based in California, US, Mithradote Bio, Inc.
Where is Mithradote Bio headquartered?
Mithradote Bio is headquartered in San Diego, US.
Which VCs invest in companies like Mithradote Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mithradote Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Mithradote Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.